Study on the drug resistance and β-lactamases of Pseudomonas aeruginosa

Zhonghua Jiehe he Huxi Zazhi

Volumn 28, Issue 4, 2005, Pages 258-262

  Wang, Jie ^a   Zhou, Jian Ying ^a   Yu, Yun Song ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

lactamases; Drug resistance, microbial; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 33645123548     PISSN: 10010939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. National Committee for Clinical Laboratory Standards. Performance standards for antmicrobial susceptibility testing: disk diffusion supplemental tables. NCCLS document, M100-S13(M2),2003.
2. Yu YS, Yang Q, Xu XW, et al. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol, 2004,53:653-656.
3. Arakawa Y, Shibata N, Shibayama K , et al. Convenient test for screening melallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol, 2000,38:40-43.
4. Senda K, Arakawa Y, Ichiyama S, et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol, 1996, 34: 2909-2913.
5. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 2002,8:321-331.
6. Yan JJ, Hsueh PR, Ko WC, et al. Melallo-β-Lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 emzyme. Antimicrob Agents Chemother, 2001, 45:2224-2228.
7. Afzal-Shah M, Woodford N, Livermore DM, et al. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 2001, 45: 583-588.
8. Poirel L, Weldhagen GF, Naas T, et al. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother, 2001,45:2598-2603.
9. Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. Antimicrob Chemother, 2002,50:673-679.
10. Poirel L, Naas T, Nicelas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-bome gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother, 2000,44:891-897.